News

Published on 30 May 2024 on Simply Wall St. via Yahoo Finance

Pleasing Signs As A Number Of Insiders Buy Heron Therapeutics Stock


Article preview image

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Heron Therapeutics, Inc. (NASDAQ:HRTX), it sends a favourable message to the company's shareholders.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

NASDAQ.HRTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is...

Key Insights Significantly high institutional ownership implies Heron Therapeutics' stock price i...

Simply Wall St. ยท via Yahoo Finance 19 Jun 2024

Pleasing Signs As A Number Of Insiders Buy Heron Therapeutics Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. via Yahoo Finance 30 May 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What...

A week ago, Heron Therapeutics, Inc. (NASDAQ:HRTX) came out with a strong set of quarterly number...

Simply Wall St. via Yahoo Finance 9 May 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript May 7, 2024 Heron Therape...

Insider Monkey via Yahoo Finance 9 May 2024

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates

Net Product Sales: Reported at $34.7 million for Q1 2024, up from $29.6 million in Q1 2023, surpa...

GuruFocus.com via Yahoo Finance 8 May 2024

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook

With the business potentially at an important milestone, we thought we'd take a closer look at He...

Simply Wall St. via Yahoo Finance 24 Apr 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Ther...

Insider Monkey via Yahoo Finance 13 Mar 2024

Investors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23%...

Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shareholders will doubtless be very grateful to see the ...

Simply Wall St. via Yahoo Finance 16 Feb 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own...

Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have sign...

Simply Wall St. via Yahoo Finance 21 Jan 2024

CEO & Director of Heron Therapeutics Craig Collard Buys 411% More Shares

Investors who take an interest in Heron Therapeutics, Inc. (NASDAQ:HRTX) should definitely note t...

Simply Wall St. via Yahoo Finance 19 Nov 2023